IL326883A - מיכל אטום במינון יחיד של תמיסת לבוטירוקסין מימית המתאימה למתן דרך הפה - Google Patents

מיכל אטום במינון יחיד של תמיסת לבוטירוקסין מימית המתאימה למתן דרך הפה

Info

Publication number
IL326883A
IL326883A IL326883A IL32688326A IL326883A IL 326883 A IL326883 A IL 326883A IL 326883 A IL326883 A IL 326883A IL 32688326 A IL32688326 A IL 32688326A IL 326883 A IL326883 A IL 326883A
Authority
IL
Israel
Prior art keywords
levothyroxine
aqueous solution
oral administration
dose container
solution suitable
Prior art date
Application number
IL326883A
Other languages
English (en)
Original Assignee
Ioulia Tseti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioulia Tseti filed Critical Ioulia Tseti
Publication of IL326883A publication Critical patent/IL326883A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL326883A 2023-09-15 2024-09-13 מיכל אטום במינון יחיד של תמיסת לבוטירוקסין מימית המתאימה למתן דרך הפה IL326883A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20230100740A GR1010807B (el) 2023-09-15 2023-09-15 Σφραγισμενος μονοδοσικος περιεκτης υδατικου διαλυματος λεβοθυροξινης καταλληλος για απο του στοματος χορηγηση
PCT/GR2024/000027 WO2025056929A1 (en) 2023-09-15 2024-09-13 Sealed single-dose container of levothyroxine aqueous solution suitable for oral administration

Publications (1)

Publication Number Publication Date
IL326883A true IL326883A (he) 2026-04-01

Family

ID=93014176

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326883A IL326883A (he) 2023-09-15 2024-09-13 מיכל אטום במינון יחיד של תמיסת לבוטירוקסין מימית המתאימה למתן דרך הפה

Country Status (6)

Country Link
CN (1) CN121816170A (he)
AU (1) AU2024343117A1 (he)
GR (1) GR1010807B (he)
IL (1) IL326883A (he)
MX (1) MX2026002284A (he)
WO (1) WO2025056929A1 (he)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR20100100508A (el) 2010-09-10 2012-04-30 Alapis Α.Β.Ε.Ε., Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια του υποθυρεοειδισμου
DK2683361T3 (da) 2011-03-10 2016-02-01 Emp Pharma Gmbh Fremgangsmåde til fremstilling af en levothyroxinopløsning
ITMI20112066A1 (it) 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
US9345772B1 (en) 2015-02-27 2016-05-24 Nilesh Parikh Liquid levothyroxine formulations
WO2017077476A1 (en) * 2015-11-04 2017-05-11 Leiutis Pharmaceuticals Pvt Ltd Novel levothyroxine formulations for oral use
EP3311844A1 (en) * 2016-10-18 2018-04-25 Altergon S.A. High-stability packaged solutions of t4 thyroid hormone
US11241382B2 (en) * 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption
GR1009815B (el) * 2019-07-25 2020-09-15 Ιουλια Κλεωνος Τσετη Μη αλκοολουχο ελευθερο απο συντηρητικα και καταλληλο για απο του στοματος χορηγηση πολυδοσικο διαλυμα λεβοθυροξινης για την αντιμετωπιση του υποθυρεοειδισμου

Also Published As

Publication number Publication date
GR1010807B (el) 2024-10-24
AU2024343117A1 (en) 2026-02-19
CN121816170A (zh) 2026-04-07
WO2025056929A1 (en) 2025-03-20
MX2026002284A (es) 2026-04-01

Similar Documents

Publication Publication Date Title
US12285413B2 (en) Anti-viral agents and methods for administration thereof
US7998510B2 (en) Low dose colonic cleansing system
MX369121B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
IL188402A0 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
RU2012155711A (ru) Жидкий назальный спрей, содержащий налтрексон в низкой дозе
ITMI20112066A1 (it) Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
MX362807B (es) Formulacion estabilizada de pemetrexed.
JP2017524471A (ja) 二重室の包装体
CO2021010326A2 (es) Composición líquida de clotrimazol envasada de dosis única
CA3301760A1 (en) Sealed single-dose container of levothyroxine aqueous solution suitable for oral administration
PT1216057E (pt) Solucao de calcitriol estavel para ser embalada em frascos
ITMI20090118A1 (it) Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione
CA3263118A1 (en) STABLE ORAL PHARMACEUTICAL FORMULATION CONTAINING RUXOLITINIB HELIFUMARATE
AP2002002423A0 (en) Bioavailable dosage form of isotretinoin.
KR20130049640A (ko) 구강유용물질을 포함하는 구강용 캡슐 및 그 제조방법
AR097023A1 (es) Composición para la gestión de las náuseas y los vómitos, método para aliviarlas, sistema de dosificación farmacéutica
IL318541A (he) פורמולציה נוזלית אוראלית תרופתית יציבה של חומר אנטי-ספמודי
BRPI0307816F1 (pt) Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia
AU2005209224A1 (en) Dermatologic soft gel compositions
MX2026002284A (es) Recipiente de dosis única sellado de solución acuosa de levotiroxina adecuado para administración oral
AU2023413677A1 (en) Medical products containing an aqueous formulation of a peptide
ZA202200227B (en) Stable oral composition of cyclophosphamide
EP4268821A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING PYRROLOQUINOLINEQUINONETRILITHIUM SALT NONHYDRATE COMPOUND, CAPSULE AND MANUFACTURING PROCESS THEREOF
TW201129557A (en) Pharmaceutical composition for oral administration
GR1011014B (el) Φαρμακευτικη συνθεση σιροπιου παρακεταμολης σε φακελισκο για αμεση καταποση